Park, Young Jin
Kim, Suna
Bang, Hyoju
Kang, Seok Chan
Cho, Sunjung
Park, Jun-Eui
Jung, Sungyoub
Kim, Ha Hyung
Funding for this research was provided by:
Korea Drug Development Fund, South Korea (RS-2022-DD123812, RS-2022-DD123812, RS-2022-DD123812, RS-2022-DD123812)
Article History
Received: 28 February 2024
Accepted: 20 May 2024
First Online: 4 June 2024
Declarations
:
: Young Jin Park, Suna Kim, Hyoju Bang, Seok Chan Kang, Sunjung Cho, Jun-Eui Park, and Sungyoub Jung are employees of Mustbio.
: The animal study using syngeneic mice was reviewed and approved by the Institutional Animal Care and Use Committee of Ahn-Gook Pharmaceutical (approval number: AG-IACUC-2022–06) of the Republic of Korea. The toxicity study in normal mice was reviewed and approved by the Institutional Animal Care and Use Committee of Chaon Co., Ltd. (approval number: CE23320). The mouse PK study was reviewed and approved by the Institutional Animal Care and Use Committee of Keyfronbio Co., Ltd., based on the Animal Protection Act of Republic of Korea (approval number: KA23104).
: Not applicable.
: Not applicable.